tradingkey.logo

LivaNova PLC

LIVN
65.930USD
-0.830-1.24%
Cierre 02/03, 16:00ETCotizaciones retrasadas 15 min
3.60BCap. mercado
PérdidaP/E TTM

Más Datos de LivaNova PLC Compañía

LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.

Información de LivaNova PLC

Símbolo de cotizaciónLIVN
Nombre de la empresaLivaNova PLC
Fecha de salida a bolsaOct 19, 2015
Director ejecutivoMakatsaria (Vladimir A)
Número de empleados2900
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 19
Dirección20 Eastbourne Terrace
CiudadLONDON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited Kingdom
Código postalW2 6LG
Teléfono442033250662
Sitio Webhttps://www.livanova.com/
Símbolo de cotizaciónLIVN
Fecha de salida a bolsaOct 19, 2015
Director ejecutivoMakatsaria (Vladimir A)

Ejecutivos de LivaNova PLC

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
32.57K
+4259.00%
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
26.68K
--
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
12.75K
--
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
+1810.00%
Franco Poletti ,
Franco Poletti ,
President, Cardiopulmonary Business Unit
President, Cardiopulmonary Business Unit
9.07K
+551.00%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
9.06K
+3006.00%
Mr. Francesco Bianchi
Mr. Francesco Bianchi
Independent Director
Independent Director
9.03K
-1500.00%
Mr. Michael Damon Hutchinson
Mr. Michael Damon Hutchinson
Senior Vice President, Chief Legal Officer, Company Secretary
Senior Vice President, Chief Legal Officer, Company Secretary
6.80K
+1132.00%
Ms. Brooke Story
Ms. Brooke Story
Independent Director
Independent Director
6.23K
-250.00%
Ms. Susan M. Podlogar
Ms. Susan M. Podlogar
Independent Director
Independent Director
2.09K
+2086.00%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
32.57K
+4259.00%
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
26.68K
--
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
12.75K
--
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
+1810.00%
Franco Poletti ,
Franco Poletti ,
President, Cardiopulmonary Business Unit
President, Cardiopulmonary Business Unit
9.07K
+551.00%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
9.06K
+3006.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
190.45M
53.23%
Rest of World
99.62M
27.85%
Europe
67.68M
18.92%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
11.60%
PRIMECAP Management Company
8.14%
Millennium Management LLC
5.44%
Artisan Partners Limited Partnership
4.44%
Wellington Management Company, LLP
4.30%
Otro
66.08%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
11.60%
PRIMECAP Management Company
8.14%
Millennium Management LLC
5.44%
Artisan Partners Limited Partnership
4.44%
Wellington Management Company, LLP
4.30%
Otro
66.08%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
50.08%
Investment Advisor/Hedge Fund
36.00%
Hedge Fund
13.06%
Research Firm
3.21%
Pension Fund
2.27%
Bank and Trust
1.31%
Individual Investor
0.37%
Sovereign Wealth Fund
0.09%
Insurance Company
0.03%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
570
57.85M
105.93%
-10.56M
2025Q3
562
56.86M
104.13%
-8.50M
2025Q2
564
56.85M
104.11%
-6.95M
2025Q1
581
56.61M
103.82%
-8.04M
2024Q4
586
56.98M
104.84%
-8.56M
2024Q3
563
55.15M
101.56%
-9.48M
2024Q2
546
57.21M
105.64%
-8.52M
2024Q1
547
58.00M
107.51%
-6.90M
2023Q4
532
56.62M
105.11%
-7.28M
2023Q3
527
56.14M
104.20%
-8.51M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
6.34M
11.6%
-38.63K
-0.61%
Sep 30, 2025
PRIMECAP Management Company
4.44M
8.14%
-196.52K
-4.23%
Sep 30, 2025
Millennium Management LLC
2.97M
5.44%
+544.03K
+22.43%
Sep 30, 2025
Artisan Partners Limited Partnership
2.43M
4.44%
+1.18M
+94.54%
Sep 30, 2025
Wellington Management Company, LLP
2.35M
4.3%
+1.07M
+83.51%
Sep 30, 2025
The Vanguard Group, Inc.
2.28M
4.18%
-157.70K
-6.46%
Sep 30, 2025
State Street Investment Management (US)
2.06M
3.76%
-25.71K
-1.24%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.72M
3.15%
+106.89K
+6.62%
Sep 30, 2025
AQR Capital Management, LLC
1.66M
3.04%
-390.84K
-19.07%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.45M
2.65%
+16.35K
+1.14%
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
State Street SPDR S&P Health Care Equipment ETF
1.66%
JPMorgan Active Small Cap Value ETF
1.43%
Invesco NASDAQ Future Gen 200 ETF
0.5%
Simplify Health Care ETF
0.43%
Global X Aging Population ETF
0.42%
JPMorgan Fundamental Data Science Small Core ETF
0.37%
Avantis US Small Cap Equity ETF
0.34%
iShares U.S. Medical Devices ETF
0.34%
WisdomTree US SmallCap Fund
0.33%
Federated Hermes MDT Small Cap Core ETF
0.33%
Ver más
State Street SPDR S&P Health Care Equipment ETF
Proporción1.66%
JPMorgan Active Small Cap Value ETF
Proporción1.43%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.5%
Simplify Health Care ETF
Proporción0.43%
Global X Aging Population ETF
Proporción0.42%
JPMorgan Fundamental Data Science Small Core ETF
Proporción0.37%
Avantis US Small Cap Equity ETF
Proporción0.34%
iShares U.S. Medical Devices ETF
Proporción0.34%
WisdomTree US SmallCap Fund
Proporción0.33%
Federated Hermes MDT Small Cap Core ETF
Proporción0.33%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI